Galea M H, Blamey R W, Elston C E, Ellis I O
Nottingham City Hospital, U.K.
Breast Cancer Res Treat. 1992;22(3):207-19. doi: 10.1007/BF01840834.
In 1982 we constructed a prognostic index for patients with primary, operable breast cancer. This index was based on a retrospective analysis of 9 factors in 387 patients. Only 3 of the factors (tumour size, stage of disease, and tumour grade) remained significant on multivariate analysis. The index was subsequently validated in a prospective study of 320 patients. We now present the results of applying this prognostic index to all of the first 1,629 patients in our series of operable breast cancer up to the age of 70. We have used the index to define three subsets of patients with different chances of dying from breast cancer: 1) good prognosis, comprising 29% of patients with 80% 15-year survival; 2) moderate prognosis, 54% of patients with 42% 15-year survival; 3) poor prognosis, 17% of patients with 13% 15-year survival. The 15-year survival of an age-matched female population was 83%.
1982年,我们为原发性可手术乳腺癌患者构建了一个预后指数。该指数基于对387例患者的9个因素进行的回顾性分析。多因素分析显示,仅有3个因素(肿瘤大小、疾病分期和肿瘤分级)具有显著性。随后,该指数在一项对320例患者的前瞻性研究中得到验证。我们现在展示将这个预后指数应用于我们系列中年龄在70岁及以下的前1629例可手术乳腺癌患者的结果。我们使用该指数定义了三组乳腺癌死亡风险不同的患者:1)预后良好组,占患者总数的29%,15年生存率为80%;2)预后中等组,占患者总数的54%,15年生存率为42%;3)预后不良组,占患者总数的17%,15年生存率为13%。年龄匹配女性人群的15年生存率为83%。